United States - English - NLM (National Library of Medicine)

pharmgate animal health - chlortetracycline calcium (unii: nr4b2sx17s) (chlortetracycline - unii:wck1kiq23q) - chlortetracycline hydrochloride 198 g in 1 kg - active drug ingredients: chlortetracycline as chlortetracycline calcium complex equivalent to 90 grams chlortetracycline hydrochloride/lb. ingredients: chlortetracycline, calcium carbonate, roughage products and mineral oil. for use in the manufacture of medicated feeds.

United States - English - NLM (National Library of Medicine)

pharmgate animal health - chlortetracycline calcium (unii: nr4b2sx17s) (chlortetracycline - unii:wck1kiq23q) - chlortetracycline hydrochloride 220 g in 1 kg - active drug ingredients: chlortetracycline as chlortetracycline calcium complex equivalent to 100 grams chlortetracycline hydrochloride/lb. ingredients: chlortetracycline, calcium carbonate, roughage products and mineral oil. for use in the manufacture of medicated feeds.

United States - English - NLM (National Library of Medicine)

h.j. harkins company, inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyog

United States - English - NLM (National Library of Medicine)

pharmgate animal health - chlortetracycline calcium (unii: nr4b2sx17s) (chlortetracycline - unii:wck1kiq23q) - chlortetracycline hydrochloride 110 g in 1 kg - active drug ingredients: chlortetracycline as chlortetracycline calcium complex equivalent to 50 grams chlortetracycline hydrochloride/lb. ingredients: chlortetracycline, calcium carbonate, roughage products and mineral oil. for use in the manufacture of medicated feeds.

United States - English - NLM (National Library of Medicine)

pharmgate animal health - chlortetracycline calcium (unii: nr4b2sx17s) (chlortetracycline - unii:wck1kiq23q) - chlortetracycline hydrochloride 110 g in 1 kg - active drug ingredients: chlortetracycline as chlortetracycline calcium complex equivalent to 50 grams chlortetracycline hydrochloride/lb. ingredients: chlortetracycline, calcium carbonate, roughage products and mineral oil. for use in the manufacture of medicated feeds.

United States - English - NLM (National Library of Medicine)

pharmgate animal health - chlortetracycline hydrochloride (unii: o1gx33on8r) (chlortetracycline - unii:wck1kiq23q) - chlortetracycline hydrochloride 0.141 g in 1 g - indications and directions for use medicate chickens and turkeys continuously at the first clinical signs of disease and continue for 7 to 14 consecutive days. the dosage ranges permitted provide for different levels based on the severity of the infection. if improvement is not noted in 24-48 hours, consult a veterinarian or a diagnostic laboratory to determine diagnoses and for advice regarding the optimal level of the drug where ranges are permitted. water medicators: dissolve the contents of one 25.6 oz packet in 100 oz of fresh water to prepare a stock solution, that when metered at the rate of 1 oz per gallon of drinking water, will deliver 1000 mg of chlortetracycline hcl per gallon. at this rate, a gallon of drinking water will treat a 100 lb pig or a 100 lb calf at the rate of 10 mg per lb of body weight for one day.

United States - English - NLM (National Library of Medicine)

versapharm incorporated - demeclocycline hydrochloride (unii: 29o079ntyt) (demeclocycline - unii:5r5w9ici6o) - demeclocycline hydrochloride 150 mg - demeclocycline hydrochloride is indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions below: rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae; respiratory tract infections caused by mycoplasma pneumoniae lymphogranuloma venereum due to chlamydia trachomatis psittacosis (ornithosis) due to chlamydia psittaci trachoma due to chlamydia trachomatis, although the infectious agent is not always eliminated as judged by immunofluorescence inclusion conjunctivitis caused by chlamydia trachomatis nongonococcal urethritis in adults caused by ureaplasma urealyticum or chlamydia trachomatis relapsing fever due to borrelia recurrentis chancroid caused by haemophilus ducreyi plague due to yersinia pestis tularemia due to francisella tularensis cholera caused by vibrio cholerae campylobacter fetus infections caused by campylobacter fetus brucellosis due to

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyog

United States - English - NLM (National Library of Medicine)

contract pharmacy services-pa - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyog

United States - English - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyog